| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 07/27/2005 | CN1646143A Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 07/27/2005 | CN1646135A Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention |
| 07/27/2005 | CN1646131A Novel compounds |
| 07/27/2005 | CN1646120A Antineoplastic combinations |
| 07/27/2005 | CN1646115A Treating benign prostate hyperplasia with SARMS |
| 07/27/2005 | CN1646110A Tolterodine salts |
| 07/27/2005 | CN1646103A 高药物载荷片剂 High drug load tablets |
| 07/27/2005 | CN1646093A Method and composition for treatment of inflammation and AIDS-associated neurological disorders |
| 07/27/2005 | CN1212151C Capsule of cordyceps |
| 07/27/2005 | CN1212147C Compound preparation of Chinese herbal medicine for treating chronic prostatitis and its preparing method |
| 07/27/2005 | CN1212134C Commpound Chinese medicine preparation for treating urinary system infection and prostatitis and its preparing process |
| 07/26/2005 | US6921763 Protein kinase inhibitors |
| 07/26/2005 | US6921761 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 07/26/2005 | CA2152902C Selective ligands of receptors 5-ht1d-5ht1b derived from indole-piperazine useful as medicaments |
| 07/21/2005 | WO2005065700A1 Life-prolonging agent comprising polished rice-origin components as the active ingredient |
| 07/21/2005 | US20050159491 Cerebrovascular and cardiovascular diseases; hot water extracting danshen plant and chromatographic separation on polyamide column; high yield, low cost, quality |
| 07/21/2005 | US20050159474 Chemical compounds |
| 07/21/2005 | US20050159467 5-Aryltetrazole compounds and uses thereof |
| 07/21/2005 | US20050159461 Treating cancer with a synergistic mixtures; anticarcinogenic agents; epothilone has secondary amide instead of an ester |
| 07/21/2005 | US20050159456 Method of treating of demyelinating diseases or conditions |
| 07/21/2005 | US20050159452 Nociceptin analogs |
| 07/21/2005 | US20050159451 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 07/21/2005 | US20050159437 Pharmaceutical agents |
| 07/21/2005 | US20050159421 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 07/21/2005 | US20050159418 Nitrogen compounds used as xanthine oxidase inhibitors, for prophylaxis of inflammation, reperfusion injuries, gout or inflammatory bowel disorders |
| 07/21/2005 | US20050159409 with a hexahydro-5-oxo-4-phenylpyrimido[4,5-b][1,5]diazocine or tetrahydro-5H-pyrimido[4,5-e][1,4]diazepin e ring; treating dysuria, especially increased urinary frequency or incontinence |
| 07/21/2005 | US20050159407 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 07/21/2005 | US20050159405 Substituted 10-aryl-11h-benzo[b]fluourenes and 7-aryl-5, 6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 07/21/2005 | US20050159337 Use of botulinum toxin therapy for treatment of overactive bladder |
| 07/21/2005 | US20050159335 Pharmaceutical administration form for peptides, process for its preparation, and use |
| 07/21/2005 | US20050159333 Carbachol, neurokinin A, P2X receptor antagonist, electrical stimulus, to inhibit polypeptide in Rho associated kinase pathway; lower urinary tract disorders, overactive bladder |
| 07/21/2005 | US20050158721 Using overexpression of senescence-associated genes as diagnostic/prognostic indicator of organ rejection/failure |
| 07/21/2005 | US20050158288 Methods of organ regeneration |
| 07/20/2005 | EP1555266A1 Remedies or preventives for urinary frequency or urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group |
| 07/20/2005 | EP1554281A2 Process for preparing certain pyrrolotriazine compounds |
| 07/20/2005 | EP1554275A2 Compounds |
| 07/20/2005 | EP1554268A1 Pyrazole inhibitors of the transforming growth factor |
| 07/20/2005 | EP1554256A1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 07/20/2005 | EP1554253A1 Imidazolium cxcr3 inhibitors |
| 07/20/2005 | EP1553973A2 eNOS MUTANTS USEFUL FOR GENE THERAPY |
| 07/20/2005 | EP1553972A1 Method of treating chronic pelvic pain syndrome by administration of chrorionic gonadotropin |
| 07/20/2005 | EP1553971A2 THERAPIES FOR RENAL FAILURE USING INTERFERON-b |
| 07/20/2005 | EP1553912A1 Compositions and methods for the diagnosis and treatment of tumor |
| 07/20/2005 | EP1472251B1 Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals |
| 07/20/2005 | EP1392670B1 Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives |
| 07/20/2005 | EP1381606B1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 07/20/2005 | EP1286673B8 Ligands of integrin receptors |
| 07/20/2005 | EP1284959B1 Compounds for modulating the rage receptor |
| 07/20/2005 | EP1272484B1 Benzoamide piperidine compounds as substance p antagonists |
| 07/20/2005 | EP1261328B1 Il-8 receptor antagonists |
| 07/20/2005 | EP1244672B1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors |
| 07/20/2005 | EP1129077B9 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors |
| 07/20/2005 | EP1011648B2 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer |
| 07/20/2005 | EP0789761B1 Human scf, a splice variant thereof, its pharmaceutical use |
| 07/20/2005 | CN1643137A Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 07/20/2005 | CN1643135A Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 07/20/2005 | CN1642983A Antibodies against of C5aR and use thereof |
| 07/20/2005 | CN1642980A Antagonistic anti-hFAS ligand human antibodies and fragments thereof |
| 07/20/2005 | CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642945A Stable hydrate of a muscarinic receptor antagonist |
| 07/20/2005 | CN1642944A (3Z) -3-(2, 3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 07/20/2005 | CN1642918A Novel hererocyclic compound and preparation thereof and medicine composition containing same and use thereof in medicine |
| 07/20/2005 | CN1642917A Non-peptide GnRH antagonists |
| 07/20/2005 | CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642574A Remedies for glomerular diseases |
| 07/20/2005 | CN1642573A Combination of an aldosterone receptor antagonist and a fibric acid derivative |
| 07/20/2005 | CN1642559A Combination comprising an HMG-CoA reductase inhibitor and an insulin secretor enhancer or an insulin sensitizer |
| 07/20/2005 | CN1642557A Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative |
| 07/20/2005 | CN1642556A Combination of an aldosterone receptor antagonist and a bile acid sequestering agent |
| 07/20/2005 | CN1642551A Inhibitors of histone deacetylase |
| 07/20/2005 | CN1642550A Beta-sheet mimetics and composition and methods relating thereto |
| 07/20/2005 | CN1640873A Separation and extraction of flavone natural product active component for treating prostating disorders and medicinal preparation preparing and use thereof |
| 07/20/2005 | CN1640473A Urinary calculus dissolving solution |
| 07/20/2005 | CN1640419A Chinese medicine composition for treating stone |
| 07/20/2005 | CN1640394A Andrographolide sulfonic acid sodium lyophilized powder for injection and its preparing method |
| 07/20/2005 | CN1211383C Process for making substituted 8-arylquinolinium benzenesulfonate |
| 07/20/2005 | CN1211375C Thiazole-derivatives |
| 07/20/2005 | CN1211374C Heterocyclic derivative, its preparation method and medicine compositioncontaining them |
| 07/20/2005 | CN1211373C 2,d-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 07/20/2005 | CN1211368C Amorphous torasemide modification |
| 07/20/2005 | CN1211367C Prostaglandin agonists and their use to treat bone disorders |
| 07/20/2005 | CN1211120C Injection for treating hydrocele of testis |
| 07/19/2005 | US6919470 Aryl and heteroaryl sulfonates |
| 07/19/2005 | US6919377 Cyclohexylamine derivative as subtype selective NMDA receptor antagonists |
| 07/19/2005 | US6919371 Antidiabetic agents; dietetics; gastrointestinal disorders |
| 07/19/2005 | US6919362 For use as hypoglycaemic and hypolipidaemic agents |
| 07/19/2005 | US6919355 Amide derivatives as NMDA receptor antagonists |
| 07/19/2005 | US6919353 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents |
| 07/19/2005 | US6919349 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 07/19/2005 | US6919343 N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives |
| 07/19/2005 | US6919340 Kinase moderators; controlling gene expression; immunosuppressants; autoimmune disease; rheumatic disorders; skin disorders; antitumor agents; anticancer agents |
| 07/19/2005 | US6919332 Enzyme inhibitors such as 5-(2-Methoxy-ethyl)-5-(4-(1-pyridin -3-yl-1H-indazol-5-yloxy)-phenoxy)-pyrimidine-2,4,6-trione, used as antiinflammatory and anticarcinogenic agents |
| 07/14/2005 | WO2005063788A1 Benzimidazole derivatives and medical uses thereof |
| 07/14/2005 | WO2005063738A1 Novel 2-heteroaryl-substituted benzimidazole derivative |
| 07/14/2005 | WO2005063704A1 Azetidine ring compounds and drugs comprising the same |
| 07/14/2005 | WO2005063702A1 Preparation of r-5-(2-(2-ethoxyphenoxyetylamino)propyl)-2- methoxybenzenesulphonamide hydrochloride of high chemical |
| 07/14/2005 | WO2005063701A1 Synthesis of optically pure (r)-5-(2-aminopropyl)-2-methoxybenzenesulphonamide |
| 07/14/2005 | WO2005063241A1 Preventive and/or therapeutic agent for disease in which mitochondrial benzodiazepine receptor participates |
| 07/14/2005 | WO2005009480A3 Implants containing codrugs |